Matthew S. Rizzo

Partner at OrbiMed Advisors LLC

Matthew S. Rizzo

Matthew S. Rizzo

Partner at OrbiMed Advisors LLC

Overview
RelSci Relationships

883

Number of Boards

2

Birthday

1973

Age

46

Contact Data
Trying to get in touch with Matthew S. Rizzo? Subscribe today to access their professional contact information and receive a one time promotion of free Contact Data credits!
Relationships
RelSci Relationships are individuals Matthew S. Rizzo likely has professional access to. A relationship does not necessarily indicate a personal connection.

Founding General Partner at OrbiMed Advisors LLC

Relationship likelihood: Strong

General Partner at OrbiMed Advisors LLC

Relationship likelihood: Strong

General Partner & Co-Head of Global Private Equity at OrbiMed Advisors LLC

Relationship likelihood: Strong

General Partner at OrbiMed Advisors LLC

Relationship likelihood: Strong

Founding Partner at OrbiMed Advisors LLC

Relationship likelihood: Strong

Interim Chief Executive Officer at Xtant Medical Holdings, Inc.

Relationship likelihood: Strong

Venture Partner at OrbiMed Advisors LLC

Relationship likelihood: Strong

Venture Partner at OrbiMed Advisors LLC

Relationship likelihood: Strong

Venture Partner at OrbiMed Advisors LLC

Relationship likelihood: Strong

Partner at OrbiMed Advisors LLC

Relationship likelihood: Strong

Paths to Matthew S. Rizzo
Potential Connections via
Relationship Science
You
Matthew S. Rizzo
Partner at OrbiMed Advisors LLC
Education
B.S.

The State University of New York is the largest comprehensive university system in the United States, educating approximately 468,000 students in more than 7,500 degree and certificate programs, and more than 1.8 million NYS citizens in professional development and personal enrichment programs, on 64 college and university campuses. There are nearly 3 million SUNY alumni worldwide.

MBA

The Fuqua School of Business (pronounced /'fju?kw?/) is the business school of Duke University in Durham, North Carolina, United States. It currently enrolls 1,340 students in degree-seeking programs. These programs include the Daytime Master of Business Administration (MBA), the Global Executive MBA, the Cross Continent MBA, the Weekend Executive MBA, Master of Management Studies: Foundations of Business, Master of Management in Clinical Informatics (MMCi), Master of Management Studies (in partnership with the Seoul National University), joint degree programs (including joint degrees in medicine, law, environmental management, forestry, public policy, and nursing), a one-year Master of Management Studies program in Kunshan, China (starting) 2012 and a Ph.D. program. Additionally, Duke Executive Education and Duke Corporate Education offer non-degree business education and professional development programs.

Career History
Partner
Current

OrbiMed Advisors focuses on investments in the global healthcare industry. They utilizes strategies based on evaluating pharmaceutical, biotechnology, medical device, healthcare services and other companies in the global healthcare sector. The instruments in which OrbiMed invests include US and non-US equities, both long and short, as well as privately placed securities, debt securities, royalty bonds and other royalty instruments, currencies, private investments in public equity securities (PIPEs), ETFs, index options, and derivatives (including swap agreements). The firm invests across the global healthcare industry, from seed-stage venture capital to large publicly-traded companies. Investments are made across three strategies: public equity, private equity, and royalty opportunities. OrbiMed Advisors manages a series of public equity funds, including long/short event-driven funds and closed-end investment trusts. They invest across all types of publicly-traded companies, from biopharmaceuticals to medical devices and healthcare services worldwide. OrbiMed's private equity strategy is broad and flexible, investing from start-ups through growth equity. OrbiMed is typically a lead investor, seeking to help build our portfolio companies. Their geographic focus includes North America, Asia, Europe and Israel. For Royal Opportunities strategy, OrbiMed provides commercial-stage healthcare companies with non-dilutive structured debt capital. Additionally, they can monetize royalty streams, providing valuable financing solutions to owners of intellectual property.

Professional
Current

Orbimed Royalty Opportunities II LP invests in healthcare royalty companies located in the US. The fund provides structured debt capital to healthcare companies with investment size between $20 and $150 million.

Senior Director-Business Development
Prior

Ikaria, Inc. operates as a biotherapeutics company focused on developing and commercializing innovative therapeutics and interventions designed to meet the medical needs of critically ill patients. It offers INOMAX for inhalation, which is used to treat newborns suffering from hypoxic respiratory failure, and is making a major impact on the critical care environment. The company was founded on August 18, 2006 and is headquartered in Clinton, NJ.

Boards & Committees
Director
2018 - Current

Xtant Medical Holdings, Inc. operates as a holding company, which supplies orthopedic and spine surgery products. The firm operates through its subsidiaries, Bacterin International, Inc. and X-spine Systems, Inc. Bacterin International develops, manufactures, and markets biologics products to domestic and international markets. Its products are bone graft, which are used in promotion of skull healing following neurosurgery and subchondral bone repair in knee and other joint surgeries; and custom surgical products used for allografts. X-spine Systems is a manufacturer of implants and instruments for surgery of the spine and sacroiliac joint. Its products are used for the treatment of degenerative spine disorders. The company was founded in 2006 and is headquartered in Belgrade, MT.

Director
Current

OmniGuide, Inc. develops advanced energy surgical solutions. It offers gynecology, head and neck, otolaryngology and otology services. The firm also provides enhance surgical accuracy, access and control for minimally invasive surgery, laparoscopy and robotic-assisted surgical products. The was founded by Yoel Fink, John D. Joannopoulos, Edwin L. Thomas and Uri Kolodny in 2000 and is headquartered in Lexington, MA.

Transactions
Details Hidden

Recro Pharma, Inc., Recro Pharma LLC purchase Alkermes Gainesville LLC from Alkermes Plc

This web site is not endorsed by, directly affiliated with, maintained, authorized, or sponsored by Matthew S. Rizzo. The use of any trade name or trademark is for identification and reference purposes only and does not imply any association with the trademark holder. The Presence of Matthew S. Rizzo's profile does not indicate a business or promotional relationship of any kind between RelSci and Matthew S. Rizzo.